Literature DB >> 11470232

Expression of the mRNA (N6-adenosine)-methyltransferase S-adenosyl-L-methionine binding subunit mRNA in cultured cells.

R A Leach1, M T Tuck.   

Abstract

Ribonuclease protection assays (RPA) were used to detect and quantitate the amount of messenger RNA (mRNA) coding for the S-adenosyl-L-methionine binding subunit (MT-A70) of the mRNA (N6-adenosine)-methyltransferase from different types of cultured cells. HeLa cells cultured in suspension were analyzed at regular intervals along a normal growth curve. It was discovered that MT-A70 mRNA was transcribed constitutively across the time-course, irrespective of the rate of cellular proliferation. Further, 11 different cell lines representing non-tumorigenic, tumorigenic, and virally-transformed tumorigenic types from Homo sapiens, Mus musculus, and Rattus norvegicus were examined for MT-A70 mRNA expression. It was found that all the cell lines expressed a long and short splice-variant form of the gene. In general, the cell lines expressed a similar total amount of the MT-A70 mRNA while statistically significant differences existed between the quantity of the long and short forms among cell types. Tumorigenic cell lines synthesized as much as a 9-fold greater amount of long form versus short form MT-A70 mRNA. Comparatively, non-tumorigenic cell lines generally expressed only a 1.5-fold greater amount of long form versus short form MT-A70 mRNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470232     DOI: 10.1016/s1357-2725(01)00071-1

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

Review 1.  N6-methyladenine RNA modification and cancers.

Authors:  Xia Wu; Lina Sang; Yuping Gong
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

Review 2.  N6-methyladenine RNA modification and cancer.

Authors:  Jun Yang; Junwen Chen; Xiang Fei; Xia Wang; Kefeng Wang
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

Review 3.  The dynamic epitranscriptome: N6-methyladenosine and gene expression control.

Authors:  Kate D Meyer; Samie R Jaffrey
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04-09       Impact factor: 94.444

4.  MTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor.

Authors:  Silin Zhong; Hongying Li; Zsuzsanna Bodi; James Button; Laurent Vespa; Michel Herzog; Rupert G Fray
Journal:  Plant Cell       Date:  2008-05-27       Impact factor: 11.277

5.  Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients.

Authors:  Yuan Li; Hao Huang; Yulan Zhu; Bin Xu; Junjun Chen; Yingting Liu; Xiao Zheng; Lujun Chen
Journal:  World J Surg Oncol       Date:  2022-09-05       Impact factor: 3.253

6.  The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.

Authors:  Dawei Zhu; Yingting Liu; Junjun Chen; Qi Wang; Yuan Li; Yulan Zhu; Jun Feng; Jingting Jiang
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

Review 7.  N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function.

Authors:  Yamei Niu; Xu Zhao; Yong-Sheng Wu; Ming-Ming Li; Xiu-Jie Wang; Yun-Gui Yang
Journal:  Genomics Proteomics Bioinformatics       Date:  2012-12-21       Impact factor: 7.691

8.  MicroRNA-1269b inhibits gastric cancer development through regulating methyltransferase-like 3 (METTL3).

Authors:  Jian Kang; Xu Huang; Weiguo Dong; Xueying Zhu; Ming Li; Ning Cui
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.